​

Baxter (BAX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BAX Stock Forecast

Baxter (BAX) stock forecast, based on 36 Wall Street analysts, predicts a 12-month average price target of $22.83, with a high of $30.00 and a low of $15.00. This represents a 16.18% increase from the last price of $19.65.

$15 $22 $29 $36 $43 $50 High: $30 Avg: $22.83 Low: $15 Last Closed Price: $19.65

BAX Stock Rating

Baxter stock's rating consensus is Hold, based on 36 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 15 Buy (41.67%), 20 Hold (55.56%), 1 Sell (2.78%), and 0 Strong Sell (0.00%).

Hold
Total 36 1 20 15 Strong Sell Sell Hold Buy Strong Buy

BAX Price Target Upside V Benchmarks

TypeNameUpside
StockBaxter16.18%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks15.56%

Price Target Trends

1M3M12M
# Anlaysts368
Avg Price Target$25.33$22.50$24.38
Last Closing Price$19.65$19.65$19.65
Upside/Downside28.91%14.50%24.07%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 2612131-17
Dec, 2512131-17
Nov, 2512131-17
Oct, 2513121-17
Sep, 2513121-17
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 09, 2026Matt MiksicBarclays$30.00$20.6945.00%52.67%
Jan 09, 2026Goldman Sachs$23.00$20.6911.16%17.05%
Jan 05, 2026Vijay KumarEvercore ISI$23.00$20.0314.83%17.05%
Dec 02, 2025Patrick WoodMorgan Stanley$15.00$19.08-21.38%-23.66%
Oct 31, 2025David RomanGoldman Sachs$22.00$18.8116.96%11.96%
Oct 30, 2025Stifel Nicolaus$22.00$19.1814.70%11.96%
Aug 04, 2025Barclays$36.00$22.4460.43%83.21%
Aug 04, 2025UBS$24.00$22.446.95%22.14%
Jan 02, 2025Vijay KumarEvercore ISI$42.00$29.2643.54%113.74%
Oct 04, 2024Travis SteedBank of America Securities$45.00$36.3223.90%129.01%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 09, 2026BarclaysOverweightOverweighthold
Jan 09, 2026Goldman SachsNeutralNeutralhold
Jan 05, 2026Evercore ISIOutperformOutperformhold
Dec 11, 2025CitigroupNeutralNeutralhold
Dec 02, 2025Morgan StanleyUnderweightUnderweighthold
Oct 31, 2025Goldman SachsNeutralNeutralhold
Oct 30, 2025Cowen & Co.HoldHoldhold
Jul 31, 2025Goldman SachsNeutralNeutraldowngrade
Jan 02, 2025Evercore ISIOutperformOutperformhold
Sep 30, 2024Deutsche BankHoldHoldhold

Financial Forecast

EPS Forecast

$-5 $-2 $1 $4 $7 $10 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.56$-4.80$5.25$-0.61----
Avg Forecast$3.60$3.56$2.59$1.83$2.47$2.72$3.15$3.40
High Forecast$3.62$3.60$2.60$1.84$2.54$2.83$3.20$3.46
Low Forecast$3.57$3.48$2.58$1.82$2.40$2.63$3.05$3.30
Surprise %-28.89%-234.83%102.70%-133.33%----

Revenue Forecast

$0 $4B $8B $12B $16B $20B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$12.78B$15.11B$14.81B$4.51B----
Avg Forecast$12.57B$15.00B$14.74B$10.56B$11.22B$11.71B$12.30B$12.84B
High Forecast$12.63B$15.14B$14.82B$10.58B$11.34B$11.72B$12.33B$13.00B
Low Forecast$12.51B$14.75B$14.72B$10.52B$11.00B$11.70B$12.27B$12.56B
Surprise %1.70%0.77%0.49%-57.25%----

Net Income Forecast

$-3B $-1B $-300M $800M $2B $3B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.28B$-2.42B$2.66B$-312.00M----
Avg Forecast$1.17B$1.02B$-76.00M$924.32M$1.25B$1.38B$1.58B$1.72B
High Forecast$1.40B$1.23B$-60.80M$929.37M$1.29B$1.43B$1.62B$1.75B
Low Forecast$935.04M$818.87M$-91.20M$919.27M$1.21B$1.33B$1.55B$1.67B
Surprise %9.86%-336.52%-3594.74%-133.75%----

BAX Forecast FAQ

Is Baxter stock a buy?

Baxter stock has a consensus rating of Hold, based on 36 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 15 Buy, 20 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Baxter is a neutral investment for most analysts.

What is Baxter's price target?

Baxter's price target, set by 36 Wall Street analysts, averages $22.83 over the next 12 months. The price target range spans from $15 at the low end to $30 at the high end, suggesting a potential 16.18% change from the previous closing price of $19.65.

How does Baxter stock forecast compare to its benchmarks?

Baxter's stock forecast shows a 16.18% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical instruments & supplies stocks industry (15.56%).

What is the breakdown of analyst ratings for Baxter over the past three months?

  • January 2026: 5.88% Strong Buy, 11.76% Buy, 76.47% Hold, 5.88% Sell, 0% Strong Sell.
  • December 2025: 5.88% Strong Buy, 11.76% Buy, 76.47% Hold, 5.88% Sell, 0% Strong Sell.
  • November 2025: 5.88% Strong Buy, 11.76% Buy, 76.47% Hold, 5.88% Sell, 0% Strong Sell.

What is Baxter’s EPS forecast?

Baxter's average annual EPS forecast for its fiscal year ending in December 2025 is $2.47, marking a -504.92% decrease from the reported $-0.61 in 2024. Estimates for the following years are $2.72 in 2026, $3.15 in 2027, and $3.4 in 2028.

What is Baxter’s revenue forecast?

Baxter's average annual revenue forecast for its fiscal year ending in December 2025 is $11.22B, reflecting a 148.70% increase from the reported $4.51B in 2024. The forecast for 2026 is $11.71B, followed by $12.3B for 2027, and $12.84B for 2028.

What is Baxter’s net income forecast?

Baxter's net income forecast for the fiscal year ending in December 2025 stands at $1.25B, representing a -500.63% decrease from the reported $-312M in 2024. Projections indicate $1.38B in 2026, $1.58B in 2027, and $1.72B in 2028.